(Q40039338)

16 September 2017

title

Response of preclinical medulloblastoma models to combination therapy with 13-cis retinoic acid and suberoylanilide hydroxamic acid (SAHA). (English)

1 reference

16 September 2017

0 references

1 reference

Susan E Spiller

1

1 reference

16 September 2017

Sally H Ditzler

series ordinal

2

1 reference

16 September 2017

Barbara J Pullar

series ordinal

3

1 reference

16 September 2017

James M Olson

series ordinal

4

1 reference

16 September 2017

publication date

5 December 2007

1 reference

Journal of Neuro-Oncology

16 September 2017

published in

1 reference

16 September 2017

volume

87

1 reference

16 September 2017

issue

2

1 reference

16 September 2017

page(s)

133-141

1 reference

https://scigraph.springernature.com/pub.10.1007/s11060-007-9505-1

16 September 2017

exact match

0 references

cites work

Retinoids in cancer therapy and chemoprevention: promise meets resistance

1 reference

12 December 2020

all-trans retinoic acid enhances cisplatin-induced apoptosis in human ovarian adenocarcinoma and in squamous head and neck cancer cells.

1 reference

12 December 2020

Incidence and trends in pediatric malignancies medulloblastoma/primitive neuroectodermal tumor: a SEER update. Surveillance Epidemiology and End Results

1 reference

12 December 2020

Clinical trial of valproic acid and all-trans retinoic acid in patients with poor-risk acute myeloid leukemia

1 reference

12 December 2020

Sequence-dependent interaction between cisplatin and histone deacetylase inhibitors in human oral squamous cell carcinoma cells.

1 reference

12 December 2020

Modulation of radiation response by histone deacetylase inhibition

1 reference

12 December 2020

BMP-2 mediates retinoid-induced apoptosis in medulloblastoma cells through a paracrine effect

1 reference

12 December 2020

Neurocognitive development of children after a cerebellar tumor in infancy: A longitudinal study

1 reference

12 December 2020

Increase in platelet count in older, poor-risk patients with acute myeloid leukemia or myelodysplastic syndrome treated with valproic acid and all-trans retinoic acid

1 reference

12 December 2020

Intellectual outcome after reduced-dose radiation therapy plus adjuvant chemotherapy for medulloblastoma: a Children's Cancer Group study

1 reference

12 December 2020

The emerging role of retinoids and retinoic acid metabolism blocking agents in the treatment of cancer

1 reference

12 December 2020

Histone deacetylase inhibitors induce cell death and enhance the susceptibility to ionizing radiation, etoposide, and TRAIL in medulloblastoma cells.

1 reference

12 December 2020

The histone deacetylase inhibitor, CBHA, inhibits growth of human neuroblastoma xenografts in vivo, alone and synergistically with all-trans retinoic acid.

1 reference

12 December 2020

Epigenetic modulation of retinoic acid receptor beta2 by the histone deacetylase inhibitor MS-275 in human renal cell carcinoma

1 reference

12 December 2020

Multiagent chemotherapy and deferred radiotherapy in infants with malignant brain tumors: a report from the Children's Cancer Group

1 reference

12 December 2020

Inhibition of histone deacetylase increases cytotoxicity to anticancer drugs targeting DNA

1 reference

12 December 2020

Whole-brain irradiation and decline in intelligence: the influence of dose and age on IQ score

1 reference

12 December 2020

Medulloblastoma in childhood: progressive intellectual deterioration.

1 reference

12 December 2020

Treatment of children with medulloblastomas with reduced-dose craniospinal radiation therapy and adjuvant chemotherapy: A Children's Cancer Group Study.

1 reference

12 December 2020

Suberoylanilide hydroxamic acid is effective in preclinical studies of medulloblastoma.

1 reference

12 December 2020

Final height in children with medulloblastoma treated with growth hormone

1 reference

12 December 2020

Pharmacokinetic studies of 13-cis-retinoic acid in pediatric patients with neuroblastoma following bone marrow transplantation.

1 reference

12 December 2020

Retinoic acid and the histone deacetylase inhibitor trichostatin a inhibit the proliferation of human renal cell carcinoma in a xenograft tumor model

1 reference

12 December 2020

Treatment of myelodysplastic syndromes with valproic acid alone or in combination with all-trans retinoic acid

1 reference

12 December 2020

Medulloblastoma: signalling a change in treatment

1 reference

12 December 2020

Role of caspases, Bid, and p53 in the apoptotic response triggered by histone deacetylase inhibitors trichostatin-A (TSA) and suberoylanilide hydroxamic acid (SAHA).

1 reference

12 December 2020

Histone deacetylase-targeted treatment restores retinoic acid signaling and differentiation in acute myeloid leukemia

1 reference

12 December 2020

Ototoxicity in children receiving platinum chemotherapy: underestimating a commonly occurring toxicity that may influence academic and social development

1 reference

12 December 2020

Effects of retinoic acid and sodium butyrate on gene expression, histone acetylation and inhibition of proliferation of melanoma cells

1 reference

12 December 2020

Endocrine outcome in children with medulloblastoma treated with 18 Gy of craniospinal radiation therapy

1 reference

12 December 2020

Apoptotic and autophagic cell death induced by histone deacetylase inhibitors

1 reference

12 December 2020

The SmoA1 mouse model reveals that notch signaling is critical for the growth and survival of sonic hedgehog-induced medulloblastomas

1 reference

12 December 2020

10.1007/S11060-007-9505-1

Identifiers

DOI

1 reference

Dimensions Publication ID

16 September 2017

1032106516

0 references

1 reference